Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2016-04-05 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
西南证券股份有限公司关于公司2015年度保荐工作报告
Audit Report / Information Classification · 90% confidence The document is titled as a "2015年度保荐工作报告" which translates to "2015 Annual Sponsorship Work Report" by Southwest Securities Co., Ltd. regarding Puluo Pharmaceutical Co., Ltd. It details the sponsorship work overview, company governance, compliance with regulations, and commitments by the company and shareholders. The content focuses on regulatory compliance, supervision, and governance related to the sponsorship activities rather than full financial statements or audit results. It is not an annual report (10-K), audit report (AR), or earnings release (ER). It is a specialized report related to sponsorship work, which aligns with the category of Audit Report / Information (AR) as it involves regulatory oversight and compliance reporting but is not a full annual report. The document length is sufficient and contains substantive content, not just an announcement or certification. Therefore, the best fit is AR (Audit Report / Information). FY 2015
2016-04-05 Chinese
关于召开2015年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2015 Annual General Meeting (AGM) of 普洛药业股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items to be discussed and voted on, registration details, and an authorization proxy form. The content focuses on the logistics and procedural details of the AGM rather than presenting the actual annual report or financial statements. The document length is 4611 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including notices and meeting details.
2016-03-24 Chinese
独立董事2015年度述职报告（张淼洪）
Board/Management Information Classification · 95% confidence The document is titled as an independent director's 2015 annual performance report, detailing attendance at board and shareholder meetings, independent opinions on various board resolutions, and other duties performed during the year. It references compliance with company law, securities law, and stock exchange rules, and includes detailed descriptions of the director's activities and opinions on company matters. The document is a report by an independent director on their annual duties and opinions, not an announcement or a brief summary. It is not a full annual report (10-K), audit report, or earnings release, but rather a management-related report focusing on governance and director duties. This fits best under Board/Management Information (MANG), which covers announcements of changes or reports related to board members and senior management activities. The document length is 1714 characters, which is short but contains substantive content about the director's work, not just an announcement or certification. Therefore, the classification is MANG with high confidence.
2016-03-24 Chinese
关于授权董事长进行理财投资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the company about authorizing the chairman to conduct financial investment using idle funds. It details the investment amount, duration, risk analysis, and control measures. There is no financial statement or report data, nor is it a presentation or meeting material. It is a regulatory announcement about capital management activities, specifically about investment authorization. This fits best under Capital/Financing Update (CAP) as it relates to company financing activities and capital use. The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2016-03-24 Chinese
独立董事2015年度述职报告（姚明龙）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2015 Annual Work Report" and details the independent director's activities, attendance at board and shareholder meetings, opinions on board resolutions, and compliance with relevant laws and regulations. It is a narrative report on the director's duties and opinions rather than a financial report or announcement. It does not contain financial statements or audit results, nor is it a notice or announcement of voting results or management changes. This type of document fits best under Board/Management Information (MANG), as it relates to the activities and reports of a board member.
2016-03-24 Chinese
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It references auditing standards and the responsibility of the company's board and auditors regarding internal control over financial reporting as of December 31, 2015. The document is issued by an accounting firm and contains an audit opinion on the effectiveness of internal controls. The length is about 1060 characters, which is relatively short but contains substantive audit content rather than just an announcement. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. It is not an Annual Report (10-K) or Interim Report (IR) because it focuses solely on internal control audit results. It is not a Regulatory Filing (RNS) because it contains an audit opinion and substantive content, not just a certification or announcement. Therefore, the correct classification is AR with high confidence. FY 2015
2016-03-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.